Other News

ROX Medical CONTROL HTN-2 Clinical Trial; First Procedure Performed

SAN CLEMENTE, Calif., October 3, 2017 – ROX Medical Inc. A privately held medical device company pioneering an innovative interventional vascular therapy for Uncontrolled Hypertension, announced today that the first patient was treated in the CONTROL HyperTeNsion (HTN)-2 clinical study, the Company’s pivotal study to evaluate the safety and effectiveness of […]

Bolton Medical Announces the First Implant of the Relay®Pro Clinical Trial for Treatment of Thoracic Aortic Dissections

Sunrise, Fla, October 3, 2017 – Bolton Medical announced the first patient has been enrolled in the RelayPro FDA Phase II Clinical Trial for Treatment of Acute Complicated Type B Thoracic Aortic Dissections.  This trial will assess the safety and efficacy of RelayPro to treat Type B dissections. Christian Shults, M.D., Cardiothoracic […]

Cardiovascular Systems to Webcast Fiscal 2018 First-Quarter Earnings Conference Call Wednesday, October 25

ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2018 first-quarter conference call on Wednesday, October 25, 2017, at 3:45 p.m. CT (4:45 p.m. ET). Scott Ward, Chairman, President and Chief Executive Officer, and Larry Betterley, Chief Financial Officer, will discuss CSI’s […]

BioCardia Receives U.S. Patent Covering Morph Product Family Design

SAN CARLOS, Calif.–(BUSINESS WIRE)–BioCardia®, Inc. (OTC: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, with clinical programs in heart failure, today announced the issuance of United States Patent No. 9,775,963 entitled, “Steerable Endoluminal Devices and Methods.” BioCardia CEO Peter Altman, PhD stated, “This new patent […]

BIOTRONIK CLS Technology Shown To Reduce Fainting In Syncope Patients By Seven-Fold

Robustly Positive Results of SPAIN Study Published in Journal of American College of Cardiology BERLIN, Germany, October 4, 2017 – BIOTRONIK’s exclusive rate responsive technology, Closed Loop Stimulation (CLS) has shown to reduce fainting in pacemaker patients with vasovagal syncope up to sevenfold. Results from the SPAIN study, the first […]

BioVentrix Announces First Patient Enrolled In The U.S. Arm Of IDE Study Of The Revivent TC TransCatheter Ventricular Enhancement Treatment

SAN RAMON, Calif., and PITTSBURGH, Pa., Oct. 4, 2017 /PRNewswire/ — BioVentrix, Inc. a pioneer of technologies and procedures for less invasive treatment of heart failure (HF), today announced enrollment of the first patient in the U.S. arm of the ALIVE pivotal clinical trial. The trial is designed to demonstrate the safety and effectiveness […]

Study Shows Significant Link Between AMI and This Common Illness

By Ken Dropiewski, Prime-Core Executive Search (ken@prime-core.com) Shingles are caused when the dormant Chickenpox virus reactivates. The result is an excruciatingly painful rash that causes inflammation of the underlying nerve tracks. This condition tends to develop at the most inopportune times such as during periods of stress and illness. It […]

New Evidence Points to Less Invasive Management for Women Suffering from Uterine Fibroids

AUSTIN, Texas–(BUSINESS WIRE)–The Journal of the Society of Laparoendoscopic Surgeons has released a publication led by Dr. Yelena Havryliuk and her colleagues from the Weill Cornell Medical College, “Symptomatic Fibroid Management: Systematic Review of the Literature.” The authors set out to define the standard of care in treating symptomatic uterine fibroids […]

Advanced Bifurcation Systems Announces Plan for Human Clinical Trials in New Brunswick, Canada

LOS ANGELES, Oct. 03, 2017 (GLOBE NEWSWIRE) — Advanced Bifurcation Systems (“ABS” or the “Company”), a clinical stage medical device company developing an innovative stenting platform which overcomes the limitations of current approaches for the treatment of bifurcation lesions in coronary angioplasties, today announced that the Company is planning to […]